Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System - Poll - MDSpire

Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System

  • By

  • David P Bui

  • Denise M Hynes

  • Edwin Wong

  • Robert Vergun

  • Lei Yan

  • Yuli Li

  • Nallakkandi Rajeevan

  • Kristin Berry

  • Hung-Mo Lin

  • Yuan Huang

  • Diana J Govier

  • Mihaela Aslan

  • George Ioannou

  • Kristina L Bajema

  • September 24, 2025

  • 0 min

Share

Original Source(s)

Budget Impact of Adopting Nirmatrelvir-Ritonavir for Treating COVID-19 in a Large Integrated Healthcare System

  • by David P Bui, Denise M Hynes, Edwin Wong, Robert Vergun, Lei Yan, Yuli Li, Nallakkandi Rajeevan, Kristin Berry, Hung-Mo Lin, Yuan Huang, Diana J Govier, Mihaela Aslan, George Ioannou, Kristina L Bajema

  • September 24, 2025

Related Content

Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.

Hantavirus Outbreak Revives COVID-Era False Health Claims — The Monitor